Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:14 PM
Ignite Modification Date:
2025-12-24 @ 11:14 PM
NCT ID:
NCT00397956
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients, 18 years of age or older
* Patients present with at least two of the following signs and symptom:
* fever (temperature\> 38c or \< 36c)
* heart rate \> 90 beats/min)
* respiratory rate\> 20 breaths/min)
* high white blood cell count \> 12,000/ul or \>10% bands)
Exclusion Criteria:
* Patient has a history of allergy or hypersensitivity (anaphylaxis) or serious adverse reaction to ertapenem or any carbapenem
* Patient has a poor chance of survival for more than 14 days.
* Patient has an apache ii score \> 15 (see attachment 3.
* Patient has an infection caused by pathogens resistant to ertapenem
* The patient requires antibiotics other than ertapenem (such as: glycopeptides, macrolides or antifungal agents)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00397956
Study Brief:
Protocol Section:
NCT00397956